Lederle Laboratories: Clinical Trials

2 trials sponsored by Lederle Laboratories, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Lederle Laboratories: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas
Mitoxantrone hydrochloride, Etoposide - Lymphoma, Non-Hodgkin, HIV Infections
Phase 2CompletedLederle Laboratories2005-06-24
Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
Mitoxantrone hydrochloride - Sarcoma, Kaposi, HIV Infections
Phase 2CompletedLederle Laboratories2005-06-24

Conditions studied

Acquired Immunodeficiency Syndrome (2)  ·  HIV Infections (2)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Sarcoma, Kaposi (1)

Interventions

Mitoxantrone (2)  ·  Etoposide (1)

Countries

United States (2)